The abstract is read at the publisher; the summary is JClub's.
Efferocytosis activates DNMT3A to promote base excision repair and suppress oxidized DNA, and DNMT3A supports tissue repair during plaque regression in a mouse atherosclerosis model.
- Why it matters: The field lacks a fully defined mechanism for how apoptotic-cell clearance reprograms macrophages toward tissue resolution in chronic inflammation, including atherosclerosis.
- What they did: Avrampou and colleagues tested whether efferocytosis triggers DNMT3A-dependent DNA repair programs, and they assessed DNMT3A’s role in plaque regression in a mouse model of atherosclerosis.
- The result: The DNMT3A-linked pathway is linked to efferocytosis-mediated tissue repair in vivo, and it suggests a therapeutic target to reduce cardiovascular events in patients with DNMT3A mutation-driven clonal hematopoiesis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.